Protocols for Laboratory Verification of Performance of the FilmArray Respiratory Panel (RP) EZ

Similar documents
Protocols for Laboratory Verification of Performance of the FilmArray Respiratory Panel (RP)

Protocols for Laboratory Verification of Performance of the FilmArray Respiratory Panel 2 plus (RP2plus)

Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel

Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel plus

Proficiency Testing Materials for use with FilmArray Panels

Lab Alert REMINDER: BioFire- FilmArray Respiratory Panel

Potential Reimbursement CPT Codes

PATHOGEN DETECTION WITH THE FILMARRAY

PAMET Continuing Education 2016

Proficiency Testing Materials for use with BioFire FilmArray Panels

FilmArray Respiratory Panel Quick Guide

Respiratory Pathogen Panel TEM-PCR Test Code:

MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels

AMPLIRUN TOTAL A RELIABLE QUALITY CONTROL SOURCE FOR NUCLEIC ACID TESTS

Test Menu. Infectious Diseases Laboratory. Division of Infectious Diseases Department of Medicine

MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels

Rapid-VIDITEST. Influenza A+B

Human Influenza A (Swine Flu) Rapid test

COLLECTION GUIDELINE FOR LABORATORY DIAGNOSIS OF COMMON VIRAL INFECTIONS

Molecular Diagnostics at Point of Care It s The Future Already. Ack!

INFECTIOUS DISEASE. Page 2

RESPIRATORY WATCH Week 3 (January 14 to January 20, 2018)*

Retrospective and Prospective Verification of the Cepheid Xpert Flu Assay

Syndromic Testing: The right test, the first time.

RESPIRATORY WATCH Week 2 (January 6, 2019 to January 12, 2019 )*

Comparison of Two Multiplex Methods for Detection of Respiratory Viruses: FilmArray RP and xtag RVP

Creating a User Defined Pneumonia-Specific Syndrome in ESSENCE. Preventive Medicine Directorate September 2016

Evaluation of the BioFire FilmArray Respiratory Panel and the GenMark esensor Respiratory Viral Panel on Lower Respiratory Tract Specimens

Rapid-VIDITEST Swine Flu

INFINITI FLU A-sH1N1 Assay Directional Package Insert (DPI)

Comparison of the eplex Respiratory Pathogen Panel with Laboratory Developed Real-

DiagCORE Respiratory Panel 2. Instructions for use PL /2018-EN

QUICK REFERENCE INSTRUCTIONS For use with Sofia only.

Line Listing and Specimen Collection. Module 5

Comparison of Luminex NxTAG Respiratory Pathogen Panel and xtag Respiratory Viral Panel FAST Version 2 for the Detection of Respiratory Viruses

Screening (and Diagnosis) of 15 Respiratory Viruses Using NAAT

October Influenza Testing for the Season. Lauren Anthony, MD, MT(ASCP)SBB Medical Director, Allina Medical Laboratories

FOR IN VITRO DIAGNOSTIC USE

M. Khanna and S. Visuri

Alkaline Phosphatase, Bone Specific

At the forefront of multiplex PCR

Influenza Weekly Surveillance Bulletin

Rapid-VIDITEST. Influenza A

Rapid Detection FAQs

Respiratory virus associated communityacquired pneumonia in Western Australian Children: case-control study

an inflammation of the bronchial tubes

Research Article The Epidemiology of Upper Respiratory Infections at a Tertiary Care Center: Prevalence, Seasonality, and Clinical Symptoms

Respiratory Multiplex Array. Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract

Molecular Diagnostics at Point of Care When will we get there; and where is there anyway?

S. Wesley Long, MD, PhD

M O L E C U L A R G E N E T I C S

New viruses causing respiratory tract infections. Eric C.J. Claas

Coordinate shipping to the Oregon State Public Health Lab through your local health department

MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 4, 2019

QUICK REFERENCE INSTRUCTIONS

Likelihood that an unsubtypeable Influenza A result. in the Luminex xtag Respiratory Virus Panel. is indicative of novel A/H1N1 (swine-like) influenza

MENU PRODUCT MOLECULAR. International Product Listing. Simplexa Molecular Kits Integrated Cycler Molecular Reagents and Primer Pairs

Influenza A & B Screening

POC TESTING: COST V CONVENIENCE. Presented by: Jim Poggi Principal Tested Insights, LLC January 29, 2019

MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 26, 2018

Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders?

Upper...and Lower Respiratory Tract Infections

QUICK REFERENCE INSTRUCTIONS For use with Sofia and Sofia 2. Rx only

and Bacterial Respiratory Tract Pathogens in Nasopharyngeal Swabs

Next Generation Rapid Diagnostics

1. Intended Use New Influenza A virus real time RT-PCR Panel is used for the detection of universal influenza A virus, universal swine Influenza A vir

TEST REQUEST INFORMATION- VIROLOGY

Influenza Weekly Surveillance Bulletin

RealLine Mycoplasma genitalium Str-Format

Influenza Weekly Surveillance Bulletin

Product # Kit Components

MICROBIOLOGICAL TESTING IN PICU

INFLUENZA (Outbreaks; hospitalized or fatal pediatric cases)

Real-Time PCR Detects Viral Nucleic Acids in Universal Transport Medium (UTM-RT) with Flocked Swabs

Redefine Performance. BD Veritor. System Revolutionizes Testing at the Point of Care. Fast. Streamlined Workflow Requires minimal hands-on time

Influenza Laboratory Surveillance DSHS Flu Surveillance Workshop Lesley Brannan, MPH

Virology Proficiency Testing Program. Restricted Category Direct Antigen Detection

ARIZONA INFLUENZA SUMMARY Week 1 (1/4/2015 1/10/2015)

Received 4 December 2006/Returned for modification 4 April 2007/Accepted 17 June 2007

Direct Comparison of Alere i and cobas Liat Influenza A and B Tests for Rapid

1. Introduction. The University of Hong Kong, Pokfulam, Hong Kong

Norgen s HIV proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad icycler

Norgen s HIV Proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad T1000 Cycler

USER GUIDE FOR SPECIMEN COLLECTION

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

4. RED AND BLUE TOP COLLECTION SWABS WILL NO LONGER BE SUPPLIED FOR BACTERIAL CULTURE

Standard Operating Procedure

In the name of God. Respiratory Viruses. An Overview

Molecular Diagnostics for Influenza & Other Respiratory Viruses

From the Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis.

RSV Surveillance in the U.S.

Recurring and Emerging Questions Related to Management of HIV-Related Opportunistic Infections. Objectives. Henry Masur MD

사람호흡기바이러스검출에대한다중 PCR 과단일 PCR 의성능비교

Innovations in nucleic acid amplification technologies. Automated platforms for NAT. Microfluidics Digital PCR Innovations in nucleic acid microarrays

Healthy Kansans living in safe and sustainable environments.

Virology Proficiency Testing Program. Restricted Category Direct Antigen Detection

SISEA Surveillance and Investigation of Epidemic Situations in South-East Asiaww

Surveillance of Influenza in Northern Ireland

Ontario Respiratory Pathogen Bulletin I

Transcription:

Protocols for Laboratory Verification of Performance of the FilmArray Respiratory Panel (RP) EZ Purpose This document provides examples of procedures to assist your laboratory in developing a protocol for the verification of FilmArray RP EZ performance on the FilmArray 2.0 EZ Configuration Instrument. Two possible verification schemes, compatible with the FilmArray RP EZ, have been designed. Each verification scheme provides positive and negative tests for each organism detected by the FilmArray RP EZ using non-clinical specimens and may be easily modified or expanded to meet specific criteria. Day-to-day variation may be evaluated by testing each sample on two separate days. To evaluate user-to-user variation, multiple laboratory technicians may test the same sample. In addition, testing patient samples for verification or to evaluate matrix effects on the performance of the FilmArray RP EZ should be done under the guidance of the Laboratory Director, but is not described here. NOTE: While the FilmArray RP EZ is CLIA waived, some clinical laboratories may wish to verify the performance specifications, according to CLIA guidelines for moderate complexity tests, prior to testing patient samples. FilmArray Intended Use FilmArray RP EZ is a multiplexed nucleic acid test intended for use with the FilmArray 2.0 EZ Configuration Instrument for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of respiratory tract infections. The following organism types and subtypes are identified using the FilmArray RP EZ: Adenovirus, Coronavirus, Human Metapneumovirus, Influenza A, Influenza A subtype H1, Influenza A subtype H3, Influenza A subtype H1-2009, Influenza B, Parainfluenza Virus, Human Rhinovirus/Enterovirus, Respiratory Syncytial Virus, Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae. The complete intended use statement and additional information about the use of the FilmArray System can be found in the FilmArray Respiratory Panel (RP) EZ Full Instruction Booklet or the FilmArray Respiratory Panel (RP) EZ Abbreviated instruction Booklet NOTE: Chlamydophila pneumoniae is sometimes referred to as Chlamydia pneumoniae. 1 P a g e FLM1-PRT-0233-01

Performance Verification: Overview Each procedure described below will generate multiple positive and negative results for each of the FilmArray Respiratory Panel (RP) EZ assays. The procedures were developed using a Respiratory Verification Panel available from ZeptoMetrix Corporation, Buffalo, NY (part number NATRVP-IDI). Two different examples of performance verification procedures are described: (1) a Simple Protocol for the verification of the FilmArray RP EZ performance on a FilmArray 2.0 EZ Configuration Instrument and (2) a Viral Transport Media (VTM) Protocol that evaluates FilmArray RP EZ performance when organisms are in a VTM sample matrix. If more than one FilmArray 2.0 EZ Configuration Instrument is in use, the laboratory director may choose to test replicates on the individual instruments. If the laboratory director chooses not to perform the verification protocol on each individual instrument, it is advised that test replicates are evenly distributed among the instruments or modules. Performance verification protocols should be designed to take advantage of the multiplex nature of the FilmArray RP EZ. Verification testing efficiency is maximized by evaluating multiple target organisms in a single test run. In addition to, or in place of, the verification protocol examples described here, a laboratory may choose to test clinical/patient samples to assess clinical sensitivity and sample matrix effects in its performance verification of the FilmArray RP EZ. Table 1. Overview of Verification Protocols Number of Verification Organisms per Protocol Pool a Sample Pools Replicates per Sample Pool Pouches Required Expected Positive Results Expected Negative Results Approximate Days of Testing b Example 1: Simple protocol 2 or 3 7 4 28 4 per organism 24 per organism 6 Example 2: Viral Transport Medium (VTM) protocol 1 19 4 76 4 per organism 72 per organism 14 a Depending on the material used for verification, pooling of organisms may not be appropriate and the values in the table may need to be modified. b The approximate number of days for testing assumes a system configured with one instrument. Performance Verification: Materials The following materials may be used to perform verification procedures: Table 2. Materials needed for recommended verification protocols Material Part Number FilmArray RP EZ Kit (30 tests) Control Organism RFIT-ASY-0120 ZeptoMetrix NATRVP-IDI a Transport Medium (e.g. Remel M4 Viral Transport Various media are appropriate Media) a Any appropriate source of organism may be used for verification of any or all of the assays in the FilmArray RP EZ. However, when alternate organism sources are used (i.e. not the ZeptoMetrix NATRVP-IDI material), the sample volumes or pooling schemes suggested in the examples below may need to be adjusted. 2 P a g e FLM1-PRT-0233-01

Performance Verification: Protocols Simple Protocol The Simple Protocol utilizes samples prepared by pooling together either 2 or 3 different organisms (ZeptoMetrix NATRVP-IDI control organism). The proposed organism pooling scheme (Table 3) should be followed to obtain the expected number of positive and negative results for each assay in a time and resourceefficient manner. NOTE: Dilution of ZeptoMetrix Respiratory Verification Panel organisms beyond levels proposed in these guidelines may lead to inconsistent results and is not recommended. The Simple Protocol can be followed to test a total of 28 pooled samples, providing 4 positive results and 24 negative results per assay. This verification protocol contains multiple strains of coronavirus and parainfluenza virus that may be detected by the FilmArray Respiratory Panel (RP) EZ. For reporting purposes, only the species will be reported. The number of samples tested per day should be determined by the individual laboratory. The testing scheme can be modified to run more samples per day based on the number of FilmArray 2.0 EZ Configuration Instrument is in use. Pooled samples can be stored overnight (or up to 3 days) at refrigeration temperature (2 8 C) for subsequent testing to evaluate day-to-day variation. Table 3. Proposed Organism Pooling Scheme Organism Pool 1 Influenza A subtype H1 Parainfluenza virus 1 Pool 2 Influenza B Parainfluenza virus 4 Coronavirus OC43 Pool 3 Human rhinovirus/enterovirus Influenza A subtype H3 Coronavirus 229E Pool 4 Adenovirus Parainfluenza virus 2 Mycoplasma pneumoniae Pool 5 Influenza A subtype H1-2009 Parainfluenza virus 3 Pool 6 Respiratory Syncytial Virus Coronavirus NL63 Human Metapneumovirus Pool 7 Bordetella pertussis Chlamydophila pneumoniae Coronavirus HKU1 Approximate volume Approximate Final Volume of Pool 1.2 ml 1.8 ml 1.8 ml 1.8 ml 1.2 ml 1.8 ml 1.8 ml An example Simple Protocol workflow is provided below. 3 P a g e FLM1-PRT-0233-01

Simple Protocol Example A proposed organism pooling scheme is presented above in Table 3. This pooling scheme provides enough material to run 4 pouches per pool. The protocol below describes testing day-to-day and user-to-user variations, but may be modified for the individual laboratory s needs. Day 1 1. Prepare three sample pools (i.e. pools #1, #2, and #3 in Table 3 above) from ZeptoMetrix NATRVP-IDI control material. NOTE: It is important to prepare only the number of sample pools that will be tested within 3 days of preparation. The suggestion to prepare 3 sample pools is based on testing 6 pouches per day. The number of samples prepared may be increased or decreased based on the laboratory s work schedule and number of FilmArray 2.0 EZ Configuration Instruments in use. a. Use a transfer pipette to remove the entire contents of the ZeptoMetrix organism vial (approximately ) and transfer to a new vial or tube. b. Repeat with the second (and third) organism to combine the appropriate organisms into a single vial or tube (approximately 1.2 ml total volume for two organisms or 1.8 ml for three organisms). NOTE: Pools 1 and 5 contain 1.2 ml and will be used to test four pouches (approximately 0.3 ml for each pouch). If the volume of the sample is not sufficient to reach the 3 rd line of the Transfer Pipette when loading sample into your pouch, note the volume shortage and proceed with testing. c. Cap and vortex prior to testing. 2. Test two samples from a single sample pool. The duplicate samples should be tested in a single day by different users. NOTE: For each sample, follow instructions in the FilmArray Respiratory Panel (RP) EZ Full Instruction Booklet and FilmArray Respiratory Panel (RP) EZ Quick Guide for pouch preparation, pouch hydration, sample loading, and sample testing. 3. Repeat Step 2 for the remaining sample pools (i.e. pools #2 and #3) to be tested that day. 4. Refrigerate samples (2 8 C) for up to 3 days for the evaluation of day-to-day variation. Day 2 To evaluate day-to-day variation, test the remaining volume of the sample pools prepared on Day 1 by repeating Step 2 above. Day 3 Prepare 3 new sample pools (i.e. pools #4, #5, and #6) as described in Step 1. Test samples according to Step 2. Day 4 To evaluate day-to-day variation, test the samples prepared on Day 3 by repeating Step 2. 4 P a g e FLM1-PRT-0233-01

Day 5-6 Repeat Steps 1 2 as above for any remaining sample pools (e.g. pool #7). Figure 1. Workflow for Simple Protocol Example 5 P a g e FLM1-PRT-0233-01

VTM Protocol The VTM Protocol utilizes samples prepared by adding a single control organism (ZeptoMetrix NATRVP-IDI control organism) to an equal volume of Viral Transport Medium (VTM) sample matrix. The VTM Protocol can be followed to test a total of 76 samples, providing 4 positive results and 72 negative results per assay. The number of samples tested per day should be determined by the individual laboratory. The testing scheme can be modified to run more samples per day based on the number of FilmArray 2.0 EZ Configuration Instruments in use. VTM samples can be stored overnight (or up to 3 days) at refrigeration temperature (2 8 C) for subsequent testing to evaluate day-to-day variation. To evaluate user-to-user variation, multiple laboratory technicians may perform testing. Table 4. Proposed VTM Sample Preparation Scheme VTM Sample Approximate volume ZeptoMetrix NATRVP-IDI Control Organism VTM An example VTM Protocol workflow is provided below. VTM Protocol Example The estimated total time to completion for this VTM Protocol verification example is 14 days for a single FilmArray 2.0 EZ Configuration Instrument. Day 1 1. Prepare three VTM Samples (i.e. sample #1, #2, #3) by mixing ZeptoMetrix NATRVP-IDI control material with VTM as proposed in Table 4. NOTE: It is important to prepare only the number of samples that will be tested within 3 days of preparation. The suggestion to prepare 3 samples is based on testing 6 pouches per day. The number of samples prepared may be increased or decreased based on the laboratory s work schedule and number of FilmArray 2.0 EZ Configuration Instruments in use. a. Pipet of VTM into a sterile tube or vial. b. Use a transfer pipette to remove the entire contents of the ZeptoMetrix organism vial (approximately ) and add organism to the tube or vial containing VTM (total sample volume for one organism in VTM will be approximately 1.2 ml). c. Ensure the VTM sample is effectively mixed by vortexing prior to testing. 2. Test two samples (pouches) from a single VTM sample. The duplicate samples should be tested in a single day by different users. NOTE: For each sample, follow instructions in the FilmArray Respiratory Panel (RP) EZ Full Instruction Booklet, FilmArray Respiratory Panel (RP) EZ Abbreviated instruction Booklet, or the FilmArray Respiratory Panel (RP) EZ Quick Guide for pouch preparation, pouch hydration, sample loading, and sample testing. 6 P a g e FLM1-PRT-0233-01

3. Repeat Step 2 for the remaining samples to be tested that day. NOTE: The approximate volume of VTM samples is 1.2 ml, which should be sufficient to test four pouches per sample (approximately 0.3 ml for each pouch). If the volume of the sample is not sufficient to reach the 3 rd line of the Transfer Pipette when loading sample into your pouch, note the volume shortage and proceed with testing. 4. Refrigerate samples (2 8 C) for up to 3 days for the evaluation of day-to-day variation. Day 2 To examine day-to-day variation, test the samples prepared on Day 1 by repeating Step 2. Day 3 4 Repeat Steps 1 4 for 3 additional samples (i.e. #4, #5, and #6). Day 5 6 Repeat Steps 1 4 for 3 additional samples (i.e. #7, #8, and #9). Day 7 8 Repeat Steps 1 4 for 2 additional samples (i.e. #10, #11, and #12). Day 9 10 Repeat steps 1 4 for the remaining samples (i.e. #13, #14 and #15). Day 11 12 Repeat steps 1 4 for the remaining samples (i.e. #16, #17, and #18). Day 13 14 Repeat steps 1 4 for the remaining samples (i.e. #19). 7 P a g e FLM1-PRT-0233-01

Figure 2. Workflow for VTM Protocol Example 8 P a g e FLM1-PRT-0233-01

Verification of loaner and repaired instruments If it becomes necessary to verify the performance of a loaner or repaired instrument, the following protocol may serve as a guideline, but should be verified by the Laboratory Director. 1. Select a few specimens and/or proficiency samples (any combination of positives and negatives) previously tested on the FilmArray Respiratory Panel (RP) EZ. The Laboratory Director should determine the appropriate number of samples to test. Two to six samples may be sufficient. Proficiency samples should not be pooled or diluted. 2. Test the selected specimens/samples on the loaner or repaired instrument and document the results. 9 P a g e FLM1-PRT-0233-01

Technical Support Contact Information BioFire is dedicated to providing the best customer support available. If you have any questions or concerns about this process, please contact the FilmArray Technical Support team for assistance. BioFire Technical Support Email: support@biofiredx.com Phone: +1-844-815-0363 10 P a g e FLM1-PRT-0233-01

FilmArray Respiratory Panel (RP) EZ Verification Record Pool 1 Organism Influenza A Representative type Subtype H1 Parainfluenza virus Type 1 Pool 2 Influenza B Parainfluenza virus Type 4 Coronavirus Pool 3 Human Rhinovirus/Enterovirus Influenza A Coronavirus Pool 4 Adenovirus OC43 Rhinovirus 1A subtype H3 229E Parainfluenza virus Type 2 Mycoplasma pneumoniae Pool 5 Influenza A subtype H1-2009 Parainfluenza virus Type 3 Pool 6 Respiratory Syncytial Virus Coronavirus Human Metapneumovirus Pool 7 Bordetella pertussis Chlamydophila pneumoniae Coronavirus Computer System Serial Number #: FilmArray RP EZ Kit Part #: Lot #: Organism/Sample Source and Lot #: NL63 HKU1 System Serial # Was the Organism Detected? No. Positive No. Negative No. Days Tested No. Users Patient Samples Tested? Reviewed by: Signature Date 11 P a g e FLM1-PRT-0233-01